Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ashcroft

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Journal of Medical Economics|February 28, 2013
Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational studyG Hechmati, S Cure, A Gouépo, et al.
Nature Communications|January 2, 2025
Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A<sub>2</sub> α for targeted cancer therapyFelicity J Ashcroft, Asimina Bourboula, Nur Mahammad, et al.
Immunity|December 13, 2003
Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerinA J Ashcroft, S M Cruickshank, P I Croucher, et al.
Blood|November 23, 2000
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cellsA C Rawstron, J A Fenton, J Ashcroft, et al.
Gut|July 19, 2006
Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motilityC C Thompson, F J Ashcroft, S Patel, et al.
Chemistry & Biology|May 27, 2014
Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assaysFabio Stossi, Michael J Bolt, Felicity J Ashcroft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma NetworkE Terpos, O Sezer, P I Croucher, et al.
BMJ Open|October 5, 2022
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A<sub>2</sub> inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trialVinzent Kevin Ortner, Berit Johansen, Kim Kilov, et al.
Journal of Medical Genetics|October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphomaL J Worrillow, A G Smith, K Scott, et al.
British Journal of Haematology|March 29, 2014
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study resultsGraham H Jackson, Gareth J Morgan, Faith E Davies, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Journal of Medical Economics|February 28, 2013
Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational studyG Hechmati, S Cure, A Gouépo, et al.
Nature Communications|January 2, 2025
Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A<sub>2</sub> α for targeted cancer therapyFelicity J Ashcroft, Asimina Bourboula, Nur Mahammad, et al.
Immunity|December 13, 2003
Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerinA J Ashcroft, S M Cruickshank, P I Croucher, et al.
Blood|November 23, 2000
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cellsA C Rawstron, J A Fenton, J Ashcroft, et al.
Gut|July 19, 2006
Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motilityC C Thompson, F J Ashcroft, S Patel, et al.
Chemistry & Biology|May 27, 2014
Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assaysFabio Stossi, Michael J Bolt, Felicity J Ashcroft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma NetworkE Terpos, O Sezer, P I Croucher, et al.
BMJ Open|October 5, 2022
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A<sub>2</sub> inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trialVinzent Kevin Ortner, Berit Johansen, Kim Kilov, et al.
Journal of Medical Genetics|October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphomaL J Worrillow, A G Smith, K Scott, et al.
British Journal of Haematology|March 29, 2014
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study resultsGraham H Jackson, Gareth J Morgan, Faith E Davies, et al.
Pageof 18